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OBJECTIVE — ToexaminethesensitivityandspeciﬁcityofA1C6.5%todiagnosediabetes
among Filipino Americans, Japanese Americans, and Native Hawaiians.
RESEARCH DESIGN AND METHODS — This was a cross-sectional study among
middle-aged adults without prior diagnosis of type 2 diabetes who completed a 2-h 75-g oral
glucose tolerance test (OGTT) and A1C measures.
RESULTS — The 933 participants had a mean age of 54.2 years, and 73% were women. A
total of 425 (45.5%) subjects had impaired fasting glucose or impaired glucose tolerance, 145
(15.5%) had type 2 diabetes (by OGTT), and 83 (8.9%) had A1C 6.5%. The sensitivity and
speciﬁcity of A1C 6.5% to deﬁne diabetes (by OGTT) was 40.0 and 96.8% and 68.9 and
95.3%,respectively(byfastingplasmaglucoseonly).However,(64.8%)ofFilipinoandJapanese
subjects with diabetes had isolated postchallenge hyperglycemia; AIC 6.5% sensitivity and
speciﬁcity was 19.1 and 92.1%, respectively, to deﬁne isolated postchallenge hyperglycemia in
the total sample.
CONCLUSIONS — A1C 6.5% had low sensitivity and may delay diagnosis of type 2
diabetes without OGTT. This limitation is exacerbated by isolated postchallenge hyperglycemia
in Asian Americans.
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A
n international expert committee
recently recommended the use of
A1C values 6.5% to diagnose
type 2 diabetes, and an A1C between 6.1
and 6.49% was considered pre-diabetic
(1). Data from the National Health and
Nutrition Examination Survey showed
low sensitivity (44%) but high speciﬁcity
(99%) (2). We recently showed similar
sensitivity (44%) but lower speciﬁcity
(79%) in older Caucasians from the Ran-
choBernardoStudy(3).Ethnicminorities
have signiﬁcantly higher A1C levels, even
after adjusting for factors that affect gly-
cemia (4,5). The utility of A1C cut point
of 6.5% has not been evaluated among
Paciﬁc Islanders and Asian Americans
whohaveanelevatedprevalenceoftype2
diabetescomparedwithCaucasians(6,7).
The objectives of this study were to deter-
minethesensitivityandspeciﬁcityofA1C
compared with the 1) fasting plasma glu-
cose (FPG) test and the 2) oral glucose
tolerance test (OGTT) to deﬁne type 2 di-
abetes among Filipino Americans, Japa-
nese Americans, and Native Hawaiians.
RESEARCH DESIGN AND
METHODS— Between 1995 and
1999, 453 Filipino-American women
were enrolled in the University of Califor-
nia San Diego Filipino Women’s Health
Study as an ethnic comparison group to
the Rancho Bernardo Study (6). Partici-
pants included community volunteers
who were recruited at churches, stores,
and festivals and through local Filipino
mediaandorganizations(6).Recruitment
materials emphasized general health and
included tests for osteoporosis and other
conditionstoreduceself-selectionbiasfor
participants with known diabetes. A total
of 382 women with no prior diagnosis of
type 2 diabetes completed a 2-h 75-g
OGTT, and A1C was measured by high-
performance liquid chromatography
using an automated analyzer (Glaxo-
SmithKline, Van Nuys, CA).
Between 1997 and 2000, a popula-
tion-based study was conducted among
1,452 residents in a rural community in
Hawaii, where participants were identi-
ﬁedbyanearlierdoor-to-doorcensusand
a cross-reference directory (7). Recruit-
ment used telephone contacts, home
visits, ﬂyers at community centers and
stores, and presentations to community
organizations and churches. A total of
210 Native Hawaiians, 171 Filipino
Americans, and 170 Japanese Americans
with no prior diagnosis of type 2 diabetes
completed an OGTT and A1C measures.
Ethnicity was based on self-report and
limited to Filipino and Japanese subjects
without reported admixture from other
ethnic groups and Hawaiians with 50%
Native Hawaiian ancestry.
Type2diabeteswasdeﬁnedbyAmer-
ican Diabetes Association criteria as an
FPG 126 mg/dl, 2-h postchallenge glu-
cose (PPG) 200 mg/dl, or A1C 6.5%
(8). Among those without diabetes, pre-
diabetes was deﬁned as having impaired
fastingglucose(IFG)(FPG:100–125mg/
dl) or impaired glucose tolerance (IGT)
(PPG: 140–199 mg/dl) (8).
Diabetes prevalence and mean A1C
valueswereageadjustedbythedirectand
least-square methods, respectively (SAS
version 9.1; SAS, Cary, NC). Receiver-
operating characteristic curves (ROCs)
were used to calculate the sensitivity and
speciﬁcity of A1C cut points for type 2
diabetes diagnosis.
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participants was 54.2 years, and 73%
were women. Mean BMI ranged from
25.3 kg/m
2 among Filipinas in San Diego
to 31.6 kg/m
2 among Hawaiians (Table
1). Mean  SD FPG was 101.6  18.5
mg/dl and mean PPG was 142.2  60.7
mg/dl. A total of 145 (15.5%) subjects
had diabetes deﬁned by an OGTT; of
these, 61 (6.5%) had an FPG 126 mg/
dl, whereas the majority (n  84 [9.0%])
hadisolatedpostchallengehyperglycemia
(PPG 200 mg/dl but FPG 126 mg/dl).
A total of 83 (8.9%) subjects had A1C
6.5%; of these, 25 (2.7%) did not have
diabetes deﬁned by OGTT. A total of 425
(45.5%) subjects had pre-diabetes, in-
cluding 182 (19.5%) with IFG only, 134
(14.4%) with IGT only, and 109 (11.7%)
with both IFG and IGT. Age-adjusted di-
abetes prevalence by OGTT (Filipino:
18.9%, Hawaiian: 12.3%, Filipino-
Hawaiian: 12.9%, Japanese: 10.9%) did
not differ markedly from unadjusted
rates.Age-adjustedmeanA1Clevelswere
6.47%amongthosewithdiabetesdeﬁned
by OGTT, 7.12% in those with diabetes
deﬁned by FPG, and 6.00% in subjects
with isolated postchallenge hyperglyce-
mia. Mean A1C was 5.16% among those
with pre-diabetes.
Using an A1C cut point of 6.5% to
deﬁne diabetes by OGTT, sensitivity was
40.0%, speciﬁcity was 96.8%, and the
area under the ROC was 0.68. AIC
6.5% to deﬁne diabetes by FPG 126
mg/dlhadasensitivityof68.9%,speciﬁc-
ity of 95.3%, and area under the curve
(AUC) of 0.82. Whereas, using AIC
6.5% to deﬁne isolated postchallenge
hyperglycemia had a very low sensitivity
of 19.1%, a speciﬁcity of 92.1%, and an
AUC of 0.56. Using A1C cut points of
6.1–6.49% to deﬁne pre-diabetes
showed that sensitivity was 14.1%, spec-
iﬁcitywas94.5%,andAUCwas0.54.The
optimal A1C cut point to deﬁne diabetes
byOGTTwas5.8%,withasensitivityof
75.9%, speciﬁcity of 80.0%, and AUC of
0.78.
CONCLUSIONS— Applying A1C
6.5% to diagnose type 2 diabetes in this
cohort of Asian Americans and Paciﬁc Is-
landers had low sensitivity and would
have failed to diagnose 60% of those with
newly diagnosed diabetes. The low
sensitivity is exacerbated by the high
prevalence of isolated postprandial hy-
perglycemia and lower A1C values in
such individuals. Similar to other Asians
with diabetes, in whom impaired -cell
function is a common defect (9,10), al-
most two-thirds of Filipino and Japanese
subjects with diabetes had isolated post-
challenge hyperglycemia. Only one-third
(35.2%) of Filipino and Japanese subjects
withdiabeteswouldhavebeendiagnosed
if screening was limited to FPG measures
only; this reinforces the importance of
OGTT in Asians. The inclusion of A1C
criteria identiﬁed a nominal proportion
(2.7%) with newly diagnosed diabetes.
Our observed sensitivity of 40% was
lower than in our Caucasian cohort in the
Rancho Bernardo Study (44%), National
HealthandNutritionExaminationSurvey
data(44%),andChinese(51%)inShang-
hai (3,2,11). Prior studies in Asia showed
that an A1C cut point of 6.1% was op-
timal among Asian Indians and A1C
6.3% was optimal among Chinese for
diagnosing type 2 diabetes by either FPG
or OGTT (11,12). We found an optimal
A1C cut point of 5.8% to diagnose dia-
betes in this cohort of Asian Americans
and Hawaiians.
Asian and Paciﬁc Islander popula-
tions are not homogenous populations,
but our sample size was insufﬁcient to
evaluate A1C measures by ethnicity.
However, to our knowledge, this is the
ﬁrstreporttoassessA1Cmeasurescollec-
tively in Asian Americans and Hawaiians.
Limitingdiabetesscreeningtofastingglu-
cose measures and A1C inadequately
identiﬁesAsianAmericanswithtype2di-
abetes. The observed low sensitivity of
A1C 6.5% to diagnose type 2 diabetes
adds to the debate about its screening
utility.
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Table 1—Glucose, diabetes, and A1C characteristics among Filipino American, Japanese
American,andNativeHawaiianadultswithoutknowntype2diabetes,SanDiegoandHawaii,
1995–2000
Total
Filipino
(San Diego)
Native
Hawaiian
Filipino
(Hawaii)
Japanese
(Hawaii)
n 993 382 210 171 170
Age (years) 54.2 57.5 46.1 53.1 57.9
BMI (kg/m
2) 26.9 25.3 31.6 25.8 25.7
IFG or IGT (%) 45.5 39.6 45.2 48.5 55.9
A1C 6.5% 8.9 12.6 5.2 8.8 4.2
Type 2 diabetes (by OGTT) (%) 15.5 22.0 10.0 11.7 11.8
FPG 126 mg/dl (%) 6.5 6.5 8.6 4.1 6.5
PPG 200 mg/dl* (%) 9.0 15.5 1.4 7.6 5.3
Age-adjusted mean A1C (%)
Type 2 diabetes (by OGTT) 6.47 6.64 6.27 6.13 6.29
FPG 126 mg/dl (%) 7.12 8.07 7.10 6.11 6.55
PPG 200 mg/dl* (%) 6.00 6.11 5.71 6.20 5.62
Sensitivity and speciﬁcity of
A1C 6.5% vs. type 2 diabetes
OGTT
FPG
126 mg/dl
PPG
200 mg/dl*
Sensitivity (%) 40.0 68.9 19.1
Speciﬁcity (%) 96.8 95.3 92.1
Positive predictive value (%) 69.9 50.6 19.3
Negative predictive value (%) 89.8 97.8 92.0
Area under ROC curve 0.68 0.82 0.56
*PPG 200 mg/dl and FPG 126 mg/dl.
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